Jefferson Vicente Urvina Muñoz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jefferson Vicente Urvina Muñoz has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Javier Aquiles Hidalgo Acosta
Universidad de Guayaquil, Ecuador
2 shared publications - Bryan Steven Pasquel Rodríguez
Department of Medicine, Universidad De Las Américas, Ecuador
1 shared publication - Cristhian Andrés Arroba Riofrio
Universidad Nacional de Chimborazo, Ecuador
1 shared publication - Doris Sherlene Domo Tomalá
Médico residente Hospital Matilde Hidalgo de Procel
1 shared publication - Erika Alejandra Zúñiga San Lucas
Blue Cross Blue Shield of Louisiana, Baton Rouge, LA, USA
1 shared publication - Gabriela Patricia Guijarro Reinoso
Universidad Técnica de Ambato
1 shared publication
Latest Publications
- Open Access
- 1 October 2025
- Published by Universidad Tecnica de Ambato - Carrera de Medicina in Mediciencias UTA
- Vol. 9 (4) , 136-150
Manejo anestésico para trombectomía percutánea en accidente cerebrovascular isquémico. Una revisión sistemática
La trombectomía mecánica o percutánea es una técnica de neurointervencionismo, que se utiliza en los casos en los que, no se ha logrado realizar trombólisis dentro de las primeras 4,5 horas, convirtiéndose en una terapia estándar para pacientes con ictus isquémico agudo que están discapacitados o presentan contraindicaciones como cirugía reciente, coagulopatía o se encuentran fuera de tiempo de ventana. Los anestésicos tienen efecto sobre el equilibrio entre el consumo y aporte de oxígeno cerebral, por cuanto el manejo anestésico durante la trombectomía mecánica garantiza la seguridad del paciente y el éxito del procedimiento. Objetivo: Determinar los resultados neurológicos, reperfusión exitosa y el manejo anestésico para el accidente cerebrovascular isquémico con trombectomía percutánea. Métodos Criterios de elegibilidad: se seleccionaron 12 ensayos clínicos aleatorizados que cumplieron con la inclusión y fueron analizados. Fuentes de información utilizadas para la búsqueda sistemática según la declaración PRISMA 2020: bases de datos como Embase, CENTRAL y Latindex, con fecha ultima de búsqueda 13 de septiembre 2025. Riesgo de sesgo de los estudios individuales: representada de forma descriptiva en la tabla de resultados. Resultados Se incluyeron 12 estudios clínicos aleatorizados demostrando que, la recuperación funcional se alcanza más rápido con la sedación consciente, presentando un porcentaje mayor de recuperación. Al analizar la reperfusión exitosa en tiempo y recanalización medida por imagen, los resultados favorecen a la anestesia general con significancia estadística, no obstante, la utilización de anestesia general se asocia con menos recuperación neurológica funcional, en comparación con la sedación consciente. Sin embargo, es considerada el procedimiento de elección en pacientes con ACV, puesto que, se consiguen mejores tasas de reperfusión del vaso afecto. Discusión La anestesia general tiene más probabilidades de recanalización exitosa, por lo que, administrar anestesia general presento resultados superiores en recanalización y la sedación consciente en recuperación neurológica funcional inicial, se necesitan más estudios clínicos sobre poblaciones específicas de evento ictus isquémico
- 1 October 2025
- Published by Universidad Tecnica de Ambato - Carrera de Medicina in Mediciencias UTA
- Vol. 9 (4) , 136-150
Open AccessManejo anestésico para trombectomía percutánea en accidente cerebrovascular isquémico. Una revisión sistemática
La trombectomía mecánica o percutánea es una técnica de neurointervencionismo, que se utiliza en los casos en los que, no se ha logrado realizar trombólisis dentro de las primeras 4,5 horas, convirtiéndose en una terapia estándar para pacientes con ictus isquémico agudo que están discapacitados o presentan contraindicaciones como cirugía reciente, coagulopatía o se encuentran fuera de tiempo de ventana. Los anestésicos tienen efecto sobre el equilibrio entre el consumo y aporte de oxígeno cerebral, por cuanto el manejo anestésico durante la trombectomía mecánica garantiza la seguridad del paciente y el éxito del procedimiento. Objetivo: Determinar los resultados neurológicos, reperfusión exitosa y el manejo anestésico para el accidente cerebrovascular isquémico con trombectomía percutánea. Métodos Criterios de elegibilidad: se seleccionaron 12 ensayos clínicos aleatorizados que cumplieron con la inclusión y fueron analizados. Fuentes de información utilizadas para la búsqueda sistemática según la declaración PRISMA 2020: bases de datos como Embase, CENTRAL y Latindex, con fecha ultima de búsqueda 13 de septiembre 2025. Riesgo de sesgo de los estudios individuales: representada de forma descriptiva en la tabla de resultados. Resultados Se incluyeron 12 estudios clínicos aleatorizados demostrando que, la recuperación funcional se alcanza más rápido con la sedación consciente, presentando un porcentaje mayor de recuperación. Al analizar la reperfusión exitosa en tiempo y recanalización medida por imagen, los resultados favorecen a la anestesia general con significancia estadística, no obstante, la utilización de anestesia general se asocia con menos recuperación neurológica funcional, en comparación con la sedación consciente. Sin embargo, es considerada el procedimiento de elección en pacientes con ACV, puesto que, se consiguen mejores tasas de reperfusión del vaso afecto. Discusión La anestesia general tiene más probabilidades de recanalización exitosa, por lo que, administrar anestesia general presento resultados superiores en recanalización y la sedación consciente en recuperación neurológica funcional inicial, se necesitan más estudios clínicos sobre poblaciones específicas de evento ictus isquémico
- Open Access
- 1 April 2025
- Published by Universidad Tecnica de Ambato - Carrera de Medicina in Mediciencias UTA
- Vol. 9 (2) , 62-72
Complicaciones y mortalidad de la neuroinfección. Una revisión sistemática
Introduction: Neuroinfection is a serious cause of neurological disease, epidemiologically it is estimated that it affects 2.5 million people in the world, at any age, with greater prevalence in regions that lack vaccination programs, such as the African continent specifically in the area called meningitis belt, where there is a high prevalence of the disease. since it is considered a health problem of great relevance worldwide. Objectives: to conduct a systematic review on complications and mortality in neuroinfection. Materials and methods: Databases such as PubMed, Wiley, SciELO, BMC, Europe PMC, Latindex, Google Scholar were searched. Observational studies, multicenter studies, randomized trials, systemic reviews, and meta-analyses were included with the research topic with a total of 50 articles. Results: According to a meta-analysis of 157 656 published cases of bacterial meningitis, the highest case fatality rate was presented by meningitis caused by Listeria monocytogenes with 27%, pneumococci 24%, meningococci 9% and H. influenzae 11%, whereas, the immunization of individuals with risk factors or areas against invasive meningococcal disease caused by Neisseria meningitidis of groups A, C, Y, W and X is a priority. A retrospective study carried out at the Eugenio Espejo Hospital in Quito revealed that 58 patients with HIV and neuroinfection accounted for 13.27% of admissions, the clinical manifestations were characterized by altered state of consciousness in 25.86%, seizures in 20.7%, headache in 15.5%, neurological focality in 39.7% of cases. Conclusions: Neuroinfection is a common pathological state in patients with risk factors or exposed to risk areas where preventive immunization is deficient and represent susceptible populations that can generate infection in the brain, presenting high morbidity and mortality and important neurological sequelae. In our country, the largest number of patients with neuroinfection is expressed by patients suffering from the human immunodeficiency virus
- 1 April 2025
- Published by Universidad Tecnica de Ambato - Carrera de Medicina in Mediciencias UTA
- Vol. 9 (2) , 62-72
Open AccessComplicaciones y mortalidad de la neuroinfección. Una revisión sistemática
Introduction: Neuroinfection is a serious cause of neurological disease, epidemiologically it is estimated that it affects 2.5 million people in the world, at any age, with greater prevalence in regions that lack vaccination programs, such as the African continent specifically in the area called meningitis belt, where there is a high prevalence of the disease. since it is considered a health problem of great relevance worldwide. Objectives: to conduct a systematic review on complications and mortality in neuroinfection. Materials and methods: Databases such as PubMed, Wiley, SciELO, BMC, Europe PMC, Latindex, Google Scholar were searched. Observational studies, multicenter studies, randomized trials, systemic reviews, and meta-analyses were included with the research topic with a total of 50 articles. Results: According to a meta-analysis of 157 656 published cases of bacterial meningitis, the highest case fatality rate was presented by meningitis caused by Listeria monocytogenes with 27%, pneumococci 24%, meningococci 9% and H. influenzae 11%, whereas, the immunization of individuals with risk factors or areas against invasive meningococcal disease caused by Neisseria meningitidis of groups A, C, Y, W and X is a priority. A retrospective study carried out at the Eugenio Espejo Hospital in Quito revealed that 58 patients with HIV and neuroinfection accounted for 13.27% of admissions, the clinical manifestations were characterized by altered state of consciousness in 25.86%, seizures in 20.7%, headache in 15.5%, neurological focality in 39.7% of cases. Conclusions: Neuroinfection is a common pathological state in patients with risk factors or exposed to risk areas where preventive immunization is deficient and represent susceptible populations that can generate infection in the brain, presenting high morbidity and mortality and important neurological sequelae. In our country, the largest number of patients with neuroinfection is expressed by patients suffering from the human immunodeficiency virus
- Open Access
- 1 April 2024
- Published by Sapienza: International Journal of Interdisciplinary Studies in Sapienza: International Journal of Interdisciplinary Studies
- Vol. 5 (2) , e24027
Integration of omics technologies for the identification of predictive biomarkers in type 2 diabetes: a comprehensive analysis of recent literature
Background. Omics technologies, such as genomics, proteomics, metabolomics, and Transcriptomics are being used for identifying biomarkers. These biomarkers are unraveling the molecular mechanisms underlying type 2 diabetes mellitus (T2DM), which can help to promote more personalized treatment strategies and advance our understanding of disease pathogenesis. Omics approaches enable the examination of genetic, protein, metabolic, and gene expression profiles more comprehensively while offering insights into T2DM risk, progression, and potential therapeutic targets. Methods: This review follows a systematic methodology, aimed at evaluating omics technology’s role in diabetes research. Utilizing literature searches, we got an initial pool of 257 studies with a rigorous selection process and narrowed the selection to 10 high-quality studies. Our methodology approach ensured the inclusion of relevant, peer-reviewed articles that contribute significantly to understanding the application of omics technologies in predicting biomarkers for type 2 diabetes. Results: The systematic review identifies ten high-quality studies illuminating substantial omics technology’s role in advancing our understanding of type 2 diabetes (T2D). Collectively, these studies demonstrate how genomics, proteomics, metagenomics, metabolomics, and Transcriptomics have uncovered novel biomarkers and molecular pathways for T2D. Our findings underscore all the omics potentials specifically for developing predictive biomarkers, enhancing diagnostics, and tailoring personalized treatment strategies. Genetic variations, metabolic alterations, and protein and RNA expression profiles were highlighted as key areas where omics technologies offer insights into the pathophysiology and management of T2D.
- 1 April 2024
- Published by Sapienza: International Journal of Interdisciplinary Studies in Sapienza: International Journal of Interdisciplinary Studies
- Vol. 5 (2) , e24027
Open AccessIntegration of omics technologies for the identification of predictive biomarkers in type 2 diabetes: a comprehensive analysis of recent literature
Background. Omics technologies, such as genomics, proteomics, metabolomics, and Transcriptomics are being used for identifying biomarkers. These biomarkers are unraveling the molecular mechanisms underlying type 2 diabetes mellitus (T2DM), which can help to promote more personalized treatment strategies and advance our understanding of disease pathogenesis. Omics approaches enable the examination of genetic, protein, metabolic, and gene expression profiles more comprehensively while offering insights into T2DM risk, progression, and potential therapeutic targets. Methods: This review follows a systematic methodology, aimed at evaluating omics technology’s role in diabetes research. Utilizing literature searches, we got an initial pool of 257 studies with a rigorous selection process and narrowed the selection to 10 high-quality studies. Our methodology approach ensured the inclusion of relevant, peer-reviewed articles that contribute significantly to understanding the application of omics technologies in predicting biomarkers for type 2 diabetes. Results: The systematic review identifies ten high-quality studies illuminating substantial omics technology’s role in advancing our understanding of type 2 diabetes (T2D). Collectively, these studies demonstrate how genomics, proteomics, metagenomics, metabolomics, and Transcriptomics have uncovered novel biomarkers and molecular pathways for T2D. Our findings underscore all the omics potentials specifically for developing predictive biomarkers, enhancing diagnostics, and tailoring personalized treatment strategies. Genetic variations, metabolic alterations, and protein and RNA expression profiles were highlighted as key areas where omics technologies offer insights into the pathophysiology and management of T2D.